Clinical trials
Hypothermia trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Unknown status | 5 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ankara City Hospital Bilkent | 2 |
| Cukurova University | 2 |
| Goztepe Prof Dr Suleyman Yalcın City Hospital | 2 |
| Istanbul University - Cerrahpasa | 2 |
| Marmara University | 2 |
| Ankara Diskapi Training and Research Hospital | 1 |
| Ankara Etlik City Hospital | 1 |
| Bezmialem Vakif University | 1 |
| Bozok University | 1 |
| Bozyaka Training and Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypothermia | 29 |
| Musculoskeletal Diseases | 2 |
| Postoperative Nausea and Vomiting | 2 |
| Premature Birth | 2 |
| Anemia, Iron-Deficiency | 1 |
| Body Temperature Changes | 1 |
| Emergence Delirium | 1 |
| Femoracetabular Impingement | 1 |
| Hemolysis | 1 |
| Hernia, Ventral | 1 |
Trials
Showing 51 to 29 of 29. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.